Bill > SB82

This bill declares existing administrative regulations 201 KAR 9:270 and 201 KAR 20:065, which govern the prescribing and dispensing of certain medications for substance use disorder, to be deficient and void, meaning they are no longer valid or enforceable. It also prohibits the State Board of Medical Licensure, the Board of Dentistry, the Kentucky Board of Nursing, and the Kentucky Board of Pharmacy from creating any new regulations that would restrict or limit the prescribing, dispensing, or administering of buprenorphine-mono-product, buprenorphine-combined-with-naloxone, or any other Schedule III, IV, or V medication approved by the U.S. Food and Drug Administration (FDA) for treating substance use disorder. These medications are often used in medication-assisted treatment (MAT) for opioid use disorder, and this bill aims to ensure easier access to them by removing regulatory barriers, declaring an emergency to allow the act to take effect immediately upon passage.

https://apps.legislature.ky.gov/record/26RS/sb82.html